Biological Sciences and Healthcare, part 5

... > Body structure > Morphologically altered structure > Morphologic abnormality > Growth alteration > Proliferation > Proliferative mass (morphologic abnormality) > Neoplasm and/or hamartoma (morphologic abnormality) > Tumor > Malignant Neoplasm (Morphology) > Malignant hematopoietic neoplasm (morphologic abnormality) > leukaemia > Lymphatic leukemia > Precursor cell lymphoblastic leukemia, not phenotyped > B lymphoblastic leukaemia lymphoma > B lymphoblastic leukemia lymphoma with t(12;21)(p13;q22); TEL-AML1 (ETV6-RUNX1) (morphologic abnormality)

... > Body structure > Morphologically altered structure > Morphologic abnormality > Lesion, NOS > Mass > Proliferative mass (morphologic abnormality) > Neoplasm and/or hamartoma (morphologic abnormality) > Tumor > Malignant Neoplasm (Morphology) > Malignant hematopoietic neoplasm (morphologic abnormality) > leukaemia > Lymphatic leukemia > Precursor cell lymphoblastic leukemia, not phenotyped > B lymphoblastic leukaemia lymphoma > B lymphoblastic leukemia lymphoma with t(12;21)(p13;q22); TEL-AML1 (ETV6-RUNX1) (morphologic abnormality)

... > Body structure > Morphologically altered structure > Morphologic abnormality > Growth alteration > Proliferation > Proliferation of hematopoietic cell type (morphologic abnormality) > Lymphoproliferative disorder (morphologic abnormality) > Lymphoid neoplasm (morphologic abnormality) > Lymphatic leukemia > Precursor cell lymphoblastic leukemia, not phenotyped > B lymphoblastic leukaemia lymphoma > B lymphoblastic leukemia lymphoma with t(12;21)(p13;q22); TEL-AML1 (ETV6-RUNX1) (morphologic abnormality)

... > Body structure > Morphologically altered structure > Morphologic abnormality > Growth alteration > Proliferation > Proliferative mass (morphologic abnormality) > Neoplasm and/or hamartoma (morphologic abnormality) > Tumor > Malignant Neoplasm (Morphology) > Malignant hematopoietic neoplasm (morphologic abnormality) > leukaemia > Acute leukemia > Precursor cell lymphoblastic leukemia, not phenotyped > B lymphoblastic leukaemia lymphoma > B lymphoblastic leukemia lymphoma with t(12;21)(p13;q22); TEL-AML1 (ETV6-RUNX1) (morphologic abnormality)

... > Body structure > Morphologically altered structure > Morphologic abnormality > Lesion, NOS > Mass > Proliferative mass (morphologic abnormality) > Neoplasm and/or hamartoma (morphologic abnormality) > Tumor > Malignant Neoplasm (Morphology) > Malignant hematopoietic neoplasm (morphologic abnormality) > leukaemia > Acute leukemia > Precursor cell lymphoblastic leukemia, not phenotyped > B lymphoblastic leukaemia lymphoma > B lymphoblastic leukemia lymphoma with t(12;21)(p13;q22); TEL-AML1 (ETV6-RUNX1) (morphologic abnormality)